Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients

BACKGROUND: Immune checkpoint therapy has dramatically changed the landscape of cancer therapy, providing an efficacious and durable therapeutic option for patients with advanced-stage disease. However, dermatologic toxicities are a well-recognized side effect in patients receiving this therapy. A s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Immunother Cancer
Glavni autori: Tetzlaff, Michael T., Nelson, Kelly C., Diab, Adi, Staerkel, Gregg A., Nagarajan, Priyadharsini, Torres-Cabala, Carlos A., Chasen, Beth A., Wargo, Jennifer A., Prieto, Victor G., Amaria, Rodabe N., Curry, Jonathan L.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5810034/
https://ncbi.nlm.nih.gov/pubmed/29433571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0323-0
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items